טוען...

Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

BACKGROUND AND OBJECTIVE: Treatment with proton pump inhibitors (PPIs) has been associated with development of hepatic encephalopathy (HE). As development of HE is a major complication after implantation of a transjugular intrahepatic portosystemic shunt (TIPS), we hypothesized that PPI treatment ma...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:United European Gastroenterol J
Main Authors: Sturm, Lukas, Bettinger, Dominik, Giesler, Max, Boettler, Tobias, Schmidt, Arthur, Buettner, Nico, Thimme, Robert, Schultheiss, Michael
פורמט: Artigo
שפה:Inglês
יצא לאור: SAGE Publications 2018
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206537/
https://ncbi.nlm.nih.gov/pubmed/30386611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640618795928
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!